HomeREGULATORY
REGULATORY

CSIMC Recommends NHI Price Listing for 15 APIs/20 Products
(Sep.7.2011)

At a general meeting on September 7, the Central Social Insurance Medical Council (CSIMC; Chuikyo) recommended NHI price listing for 15 APIs (active pharmaceutical ingredients)/20 products, including AstraZeneca’s proton pump inhibitor (PPI) Nexium capsule 10 mg and 20 mg (esomeprazole magnesium) and Astellas Pharma’s treatment for overactive bladder Betanis Tablet 25 mg and 50 mg (mirabegron). The adrenal hormone preparation EpiPen Injection 0.15 mg and 0.3 mg (adrenaline) will be added to the NHI price list on September 22. Other products will be included in the NHI price list on September 12.
> Read full story

Commentary

It’s Time to Squarely Discuss Proposed Penalty through Drug Price Cuts

Lexicon

3 price-band (bracket) grouping rule:
3価格帯ルール

The Column

Don’t Accept the Offer

Archives

MHLW Sends Alert on Kids’ Accidental Ingestion of Psychotropics, Other Drugs(Feb.10)
Asahi Kasei President to Step Down over Piling Data Scandal(Feb.10)
Daiichi Sankyo to Close UK Development Unit(Feb.10)
Otsuka Licenses US Rights for PDE4 Inhibitor to Medimetriks(Feb.10)
Ethical Drug Sales Up 5.7% in December: Crecon Report(Feb.10)

Most Read

1.
MHLW Panel Backs Approval of Novartis’s ...
2.
BMS, Pfizer to Codevelop Factor Xa Antid...
3.
Takeda to Spin Off Consumer Healthcare U...
4.
Mitsubishi Tanabe to Establish Stand-Alo...
5.
FDA Panel Backs Effectiveness of Brintel...

News Calendar